Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹16 Cr
Revenue (TTM)
₹1 Cr
Net Profit (TTM)
₹0 Cr
ROE
10.7 %
ROCE
11.4 %
P/E Ratio
52
P/B Ratio
2.1
Industry P/E
36.53
EV/EBITDA
9.1
Div. Yield
0 %
Debt to Equity
0
Book Value
₹15.4
EPS
₹0.6
Face value
10
Shares outstanding
4,996,100
CFO
₹7.10 Cr
EBITDA
₹-3.18 Cr
Net Profit
₹5.98 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Emmessar Biotech
| -26.7 | -2.9 | -2.9 | -20.3 | 11.7 | 18.6 | 9.7 |
|
BSE Healthcare
| -4.6 | 0.9 | 5.1 | 17.0 | 27.1 | 21.6 | 10.3 |
|
BSE Small Cap
| -4.4 | 1.8 | 13.8 | 1.9 | 29.5 | 33.7 | 17.0 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2018
|
|---|---|---|---|---|---|
|
Emmessar Biotech
| 66.1 | -0.9 | -10.3 | 43.0 | -40.9 |
|
BSE Small Cap
| 29.0 | 47.5 | -1.8 | 62.8 | -23.4 |
|
BSE Healthcare
| 43.1 | 37.0 | -12.1 | 20.9 | -5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Emmessar Biotech
|
33.0 | 16.5 | 0.6 | 0.3 | -172.2 | 4.1 | 52 | 2.1 |
| 727.9 | 2,093.1 | 451.8 | 50.8 | 11.4 | 16.3 | 41.2 | 6.4 | |
| 455.0 | 7,411.9 | 2,108.1 | 266.8 | 12.5 | 11.7 | 27.8 | 3.2 | |
| 355.8 | 3,569.4 | 819.8 | 69.7 | 13.9 | 11.9 | 51.2 | 5.9 | |
| 426.1 | 2,606.5 | 559.1 | -8.7 | -10.9 | -159 | -- | 3.1 | |
| 5,907.0 | 9,778.8 | 1,218.1 | 251.2 | 28.1 | -- | 38.9 | 18.2 | |
| 880.5 | 8,649.6 | 1,286.4 | 79.6 | 15.9 | 4.7 | 110.5 | 3.6 | |
| 826.8 | 7,614.5 | 4,632.7 | 358.2 | 14.8 | 15 | 2.1 | 3.0 | |
| 681.8 | 5,484.9 | 696.5 | 188.0 | 34.5 | 19.8 | 29.2 | 5.5 | |
| 884.4 | 1,853.2 | 759.9 | 61.0 | 8.7 | 12.5 | 30.4 | 3.7 |
No Review & Analysis are available.
Emmessar Biotech & Nutrition Limited, a healthcare company, manufactures and markets healthcare and nutritional products in India and internationally. It operates through Healthcare, Fine Chemicals, and Rent on Lease Land segments. The company offers... bone care, general health, muscle care, pain relief, sexual health, skin care, and skin cure products. The company was formerly known as Emmessar Chemical Industries Ltd. and changed its name to Emmessar Biotech & Nutrition Limited in April 2000. Emmessar Biotech & Nutrition Limited was founded in 1992 and is headquartered in Mumbai, India. Read more
Incorporated
1992
Chairman
--
Managing Director
Srinivasa Raghavan Mathurakavi Ayyangar
Headquarters
Raigad Dist, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The total asset value of Emmessar Biotech & Nutrition Ltd stood at ₹ 9 Cr as on 31-Mar-25
The share price of Emmessar Biotech & Nutrition Ltd is ₹33.00 (BSE) as of 20-Jun-2025 IST. Emmessar Biotech & Nutrition Ltd has given a return of 11.74% in the last 3 years.
Emmessar Biotech & Nutrition Ltd has a market capitalisation of ₹ 16 Cr as on 20-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Emmessar Biotech & Nutrition Ltd is 2.14 times as on 20-Jun-2025, a 59% discount to its peers’ median range of 5.27 times.
The P/E ratio of Emmessar Biotech & Nutrition Ltd is 52.01 times as on 20-Jun-2025, a 42% premium to its peers’ median range of 36.53 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Emmessar Biotech & Nutrition Ltd and enter the required number of quantities and click on buy to purchase the shares of Emmessar Biotech & Nutrition Ltd.
Emmessar Biotech & Nutrition Limited, a healthcare company, manufactures and markets healthcare and nutritional products in India and internationally. It operates through Healthcare, Fine Chemicals, and Rent on Lease Land segments. The company offers bone care, general health, muscle care, pain relief, sexual health, skin care, and skin cure products. The company was formerly known as Emmessar Chemical Industries Ltd. and changed its name to Emmessar Biotech & Nutrition Limited in April 2000. Emmessar Biotech & Nutrition Limited was founded in 1992 and is headquartered in Mumbai, India.
The prominent promoters of Emmessar Biotech & Nutrition Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
Emmessar Technologies Limited |
21.79%
|
|
Manar Leasing & Investments Pvt. |
10.57%
|
|
M S Raghavan |
5.68%
|
|
Hema A Shah |
5.37%
|
|
Amu Investment & Finance Pvt. |
5.2%
|
The chairman of the company is , and the managing director is Srinivasa Raghavan Mathurakavi Ayyangar.
There is no promoter pledging in Emmessar Biotech & Nutrition Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
9,779
|
|
|
8,650
|
|
|
7,614
|
|
|
7,412
|
|
|
5,485
|
|
|
3,569
|
|
|
2,607
|
|
|
2,093
|
|
|
1,853
|
| Emmessar Biotech & Nutrition Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
4.12
|
|
Operating margin(%)
|
-172.18
|
|
Net Margin(%)
|
12.18
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Emmessar Biotech & Nutrition Ltd was ₹0 Cr.
₹-0.74
(
